Product Information
Lidocaine HCl 1% Injection, 10 x 20 mL Multiple-Dose Vials — Camber Pharmaceuticals
NDC: 31722-116-32
Product Details
| Active Ingredient | Lidocaine hydrochloride 10 mg/mL (1%); 200 mg per 20 mL vial |
| Dosage Form | Sterile injectable solution, multiple-dose vial |
| Route | Infiltration and perineural administration for local or regional anesthesia/analgesia, as directed by the prescribing information |
| Package Size | 20 mL per vial; 10 vials per pack |
| Manufacturer | Camber Pharmaceuticals, Inc. |
| NDC | 31722-116-32 |
Indications and Usage
Lidocaine hydrochloride injection is indicated in adults and pediatric patients for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and obstetrical procedures.
Dosage and Administration
Dosage varies according to the procedure, area to be anesthetized, depth and duration of anesthesia required, and the patient's individual response. Use the lowest effective dose necessary to achieve the desired effect. Refer to the full prescribing information for specific dosing recommendations and maximum dosage limits.
Warnings and Precautions
- Administer only by clinicians experienced in local anesthetic use and the management of local anesthetic toxicity.
- Avoid inadvertent intravascular administration. Perform aspiration before and periodically during injection, as appropriate.
- Toxic blood concentrations may cause central nervous system and cardiovascular effects.
- Lidocaine may cause methemoglobinemia.
- Multiple-dose vials contain methylparaben as an antimicrobial preservative.
Contraindications
Contraindicated in patients with known hypersensitivity to lidocaine, other amide-type local anesthetics, or any component of the formulation.
Adverse Reactions
Adverse reactions associated with systemic lidocaine exposure may include central nervous system effects such as dizziness, tremor, drowsiness, confusion, seizures, and respiratory depression. Cardiovascular effects may include hypotension, bradycardia, arrhythmias, and cardiovascular collapse. Allergic-type reactions are uncommon but may occur.
Storage and Handling
Store at 20°C to 25°C (68°F to 77°F), with permitted excursions in accordance with USP Controlled Room Temperature requirements. Protect from excessive heat. Inspect the solution before use. Do not use if discolored or if a precipitate is present.
How Supplied
Sterile, nonpyrogenic Lidocaine HCl Injection, USP, 200 mg/20 mL (10 mg/mL), supplied in 20 mL multiple-dose vials, with 10 vials per carton.
Professional use only.
Clinical information is summarized from FDA-approved prescribing information (Structured Product Labeling). Refer to the full prescribing information via DailyMed for complete details.
If you have questions related to DSCSA compliance, transaction history, regulatory data, or quality assurance, please contact our team at compliance@dryeyerescue.com.
CLINIC ESSENTIALS
Add the Rx You Use Every Day
Already ordering your OTC inventory? Add commonly used clinic medications to the same order.
NDC 24208-730-06
NDC 24208-585-64
NDC 24208-295-25
Practices also stock
Complementary products other practices order alongside this one.




![Tobramycin Dexamethasone [TOBRADEX] 0.3%/0.1% 2.5mL](http://wholesale.dryeyerescue.com/cdn/shop/files/RX-1056-Tobramycin-Dexamethasone-01.jpg?v=1784151141&width=480)